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Lentinula edodes mycelia (LEM) solid culture extracts contain many bioactive
compounds with diverse pharmacological activities such as antitumor, antiviral, and
immunopotentiating effects. In this study, we examined the anti-influenza virus activity
of LEM in vitro and in vivo. LEM directly inhibited influenza virus growth in vitro at
early phases of infection, possibly at the entry process of viral particles to host cells.
We also found that the nasal administration of LEM increased the survival rate of
infected mice, and this was likely due to the direct action of LEM on the viral growth.
The oral administration of LEM showed prolonged median survival time of infected
mice. Histological analysis revealed that the moderate bronchiolitis was observed in
infected mice by the oral administration with LEM, and the extent of alveolitis was
dramatically reduced. The orally LEM-administered mice showed a rapid activation of
IFN-β gene expression upon influenza virus infection. These results suggest that the
immunopotentiation activity of LEM on type I IFN pathway represses the virus spread to
distal alveolar regions from peribronchiolar regions which are primary infection sites in
the mouse model. We propose that LEM has anti-influenza virus activities through the
direct action on viral growth and stimulatory activity of innate immunity.
Keywords: LEM, inflammation, influenza virus, interferon, pneumonia
INTRODUCTION
Various natural products have distinct anti-influenza virus activities, and traditional medicine
based on those natural products has shown a potential in therapy of influenza symptoms (Wang
et al., 2006). Mao-to, a Japanese traditional herbal medicine, is known to shorten the duration
of fever caused by influenza A virus infection (Kubo and Nishimura, 2007). Ko-Ken Tang, a
conventional Asian herbal medicine, inhibits influenza A virus infection through the repression
of PI3K/Akt signaling pathway activated by influenza virus infection (Wu et al., 2011). A high
molecular weight lignin-related fraction extracted from cones of Pinus parviflora Siebold et
Zucc. suppresses the influenza viral growth by preventing viral RNA synthesis (Nagata et al.,
1990; Watanabe et al., 1995). Sanicula europaea L. leaf extracts selectively inhibit influenza A
viruses, but not influenza B viruses (Turan et al., 1996). These natural products show diverse
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pharmacological activities with a variety of bioactive components
such as polyphenols, saponins, and alkaloids, although the
inhibitory mechanism on virus infection is poorly understood.
Lentinula edodes mycelia is a whole extract prepared from the
mycelial culture of Japanese edible mushroom, Lentinus edodes,
grown in a solid medium of sugar-cane bagasse and defatted
rice bran. LEM and its purified fractions have been shown to
have antiviral activities against hepatitis C virus, herpes simplex
virus, and human immunodeficiency virus (Suzuki et al., 1990;
Kawano et al., 2010; Okuno and Uno, 2011; Kim et al., 2014;
Matsuhisa et al., 2015). However, the antiviral activity of LEM
against influenza virus remains unclear. Here we examined the
inhibitory effect of LEM on influenza virus infection in vitro and
in vivo. LEM directly inhibited the virus growth of influenza virus
possibly by preventing the entry and/or uncoating processes of
viral infection. The intranasal administration of LEM increased
the survival rate of influenza virus-infected mice. In mice orally
administered with LEM, although the mortality rate was not
significantly reduced, the median survival time was prolonged
from 9 to 13 days post infection. We also found that the
oral administration of LEM reduced severe alveolitis, and the
pulmonary lesion was mainly observed at peribronchiolar region
of influenza virus-infected mice. The expression of IFN-β gene
was rapidly induced in orally LEM-treated mice upon virus
infection, indicating that LEM protects mice from influenza virus
infection by not only the direct action on viral infection but also
promoting the innate immune response.
MATERIALS AND METHODS
Biological Materials
The powder of Lentinus edodes mycelia extracts was provided
from Noda Shokukin Kogyo Co., Ltd., Japan. The powder of LEM
was dissolved in ultra-pure water (Millipore) at a concentration
of 50 mg/ml. Madin-Darby canine kidney (MDCK) cells and
human embryonic kidney 293T cells were cultured as previously
described (Mori et al., 2011). Female C57BL/6J mice (8–10-week-
old) were purchased from CLEA Japan. All in vivo experiments
were carried out according to the Guidelines for Proper Conduct
of Animal Experiments from Science Council of Japan. The
protocols for experiments with mice were approved by Animal
Care and Use Committee of the University of Tsukuba.
Virus
Influenza A/Puerto Rico/8/34 (PR8), A/WSN/33 (WSN) and
B/Shanghai/361/02 (SH361) viruses were grown at 35.5◦C for
48 h in allantoic sacs of 11-day old embryonated eggs, and then
the infected allantoic fluid was collected and stored at −80◦C
until use. The viral titer of each virus measured by plaque assays
was 2.0 × 108 pfu/ml for PR8, 2.8 × 108 pfu/ml for WSN, and
5.1× 106 pfu/ml for SH361, respectively.
Plaque Assay
A confluent monolayer culture of MDCK cells (1.0× 106 cells) in
a 6-well tissue culture plates was washed with serum-free MEM
and then was infected with 50 pfu of WSN or SH361. After virus
adsorption at 37◦C for 1 h, the cells were washed with serum-
free MEM and then overlaid with MEM containing 0.8% agarose,
0.2% BSA, 1× vitamin solution (Gibco), and 1 µg/ml TPCK-
treated trypsin (Sigma) in the presence or absence of 300µg/ml of
LEM. After incubation at 37◦C for 2–3 days, cells were fixed with
ethanol-acetic acid (1:1) solution and stained with 0.5% amide
black. To quantify the viral growth, the area of each plaque was
measured by ImageJ software (NIH). Results were represented as
a ratio of the plaque area formed in the presence of LEM to that
in the absence of LEM.
In Vivo Infection Experiment
Mice were anesthetized using isoflurane diluted at 30% in
propylene glycol prior to infection. For the nasal administration
of LEM, mice were infected intranasally with 1,000 pfu of PR8
in 50 µl of PBS with or without 1 mg/ml LEM. For the oral
administration of LEM, mice were infected intranasally with
1,000 pfu of PR8 and then administered with 1 mg/ml LEM
through drinking water during the whole period.
Mini-Replicon Reporter Assay
293T cells were transfected with viral protein expression plasmids
encoding PA, PB1, PB2, NP, and pHH21-vNS-Luc reporter
plasmid (Obayashi et al., 2008). pHH21-vNS-Luc carries firefly
luciferase gene in reverse orientation sandwiched between 23 nt-
long 5′- and 26 nt-long 3′-termini of influenza virus genome
segment 8. A plasmid encoding Renilla luciferase was used
as an internal control. At 12 h post transfection, cells were
further incubated with 300 µg/ml LEM for 6 h. The cell lysates
were prepared, and the luciferase activity was measured using
MiniLumat LB 9506 (Berthold).
Histological Analysis
For lung histological analysis, mice were infected as described
above and sacrificed at 7 days post infection. The lungs were fixed
with 10% formalin. After paraffin embedding, mice lungs were
sectioned into 2µm slices, and the sections were then subjected to
hematoxylin and eosin staining. Stained samples were observed
using DMi8 light microscopy (Leica).
RNA Analysis
Total RNAs were isolated by using RNeasy Mini Kit (Qiagen),
and were reverse transcribed with following primers: 5′-GACGA
TGCAACGGCTGGTCTG-3′ for segment 5 viral genome,
oligo(dT)20 for mRNA, and 5′-GGGAGTGGGTAATTTGCGC-
3′ for 18S rRNA. Real-time PCR was performed using FastStart
SYBR Green (Roche) with following specific primer sets: 5′-GAC
GATGCAACGGCTGGTCTG-3′ and 5′-AGCATTGTTCCAA
CTCCTTT-3′ for segment 5 and NP mRNA; 5′-GCACTGGG
TGGAATGAGACT-3′ and 5′-AGTGGAGAGCAGTTGAG
GACA-3′ for IFN-β mRNA; 5′-CTGCCATCAAGAGCCC
CTGC-3′ and 5′-CCCTTCTCCAGCTGGAAGAC-3′ for
TNF-α mRNA; 5′-AACGGCTACCACATCCAAGG-3′ and 5′-
GGGAGTGGGTAATTTGCGC-3′ for 18S rRNA. The amounts
of viral genome and mRNA were normalized by the amount of
18S rRNA, respectively.
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Flow Cytometry
Cells were collected from bronchoalveolar lavage fluid (BALF)
and resuspended in RBC lysis buffer (154 mM NH4Cl, 10 mM
KHCO3, and 0.1 mM EDTA) for 5 min. After washing the cells
with PBS containing 2% fetal bovine serum (FBS), the cells were
stained with either anti-CD45.2 or anti-IgG2a antibodies on ice
for 30 min. Flow cytometry was performed using Guava easyCyto
flow cytometer (Merck Millipore).
Enzyme-Linked Immunosorbent Assay
(ELISA)
The mice were infected intranasally with 1000 pfu of PR8. BALF
was collected by washing the trachea and lungs by injecting 2 ml
of PBS containing 0.1% BSA and was subjected to ELISA with
mouse IFN-β kit according to the manufacturer’s instruction
(PBL assay science).
Focus-Forming Assay
Pulmonary viral titer of infected mouse was determined by focus-
forming assay. Briefly, a confluent monolayer culture of MDCK
cells in a 12-well tissue culture plate containing cover slips
(4.0 × 105 cells/well) was washed with serum-free Minimum
essential medium (MEM; Nissui) and then was infected with
homogenized lung supernatants containing viruses in serum free
MEM. After incubating for 1 h at 37◦C for virus adsorption, the
cells were washed with serum-free MEM and then incubated for
4 h in DMEM containing 10% bovine fetal calf serum. Cells were
fixed with 4% PFA for 10 min and were subjected to indirect
immunofluorescence assay using anti-NP antibody as described
previously described (Kawaguchi et al., 2011). The focus forming
units (FFU) was determined by counting cells labeled with the
fluorescent antibody.
RESULTS
LEM Inhibits Influenza Virus Infection
in Vitro and in Vivo
To observe the cytotoxic effect of LEM, MDCK cells were
incubated with MEM containing 0, 5, 10, 50, 100, and 500 µg/ml
of LEM for 72 h, and then total cell numbers were counted.
LEM showed little or no cytotoxicity to MDCK cells (Figure 1A).
To next examine whether LEM inhibits influenza virus growth,
plaque assays were carried out in the absence or presence
of LEM. MDCK cell monolayers were infected with 50 pfu
of either influenza A virus (WSN; Figure 1B) or influenza
B virus (SH361; Figure 1C) and then overlaid with 0.8%
agarose in MEM containing 0, 30, 100, and 300 µg/ml LEM.
LEM showed a dose-dependent inhibition of plaque formation,
and the area of plaques in the presence of 300 µg/ml LEM
decreased to less than 15% of that in the absence of LEM
(Figures 1B,C). These results indicated that LEM shows a
broad antiviral activity against influenza viruses. We next
examined the antiviral effect of LEM on survival of infected
mice with either intranasal or oral administration of LEM
(Figure 1D). For intranasal administration of LEM, fully
FIGURE 1 | Inhibition of influenza virus infection by Lentinula edodes mycelia
(LEM) in vitro and in vivo. (A) Cytotoxicity of LEM to cell growth was measured
in the presence of 0, 5, 10, 50, 100, 500 µg/ml of LEM. The results are
averages from three independent experiments with standard deviations. (B,C)
Plaque assays were performed in the presence of 0, 30, 100, and 300 µg/ml
of LEM with WSN (B) or SH361 (C). The percentage of the plaque area in the
presence of LEM relative to that in the absence of LEM is shown (N > 50).
The results are averages from three independent experiments with standard
deviations, and the statistical significance was determined by Student’s t-test.
(D) Anesthetized mice were intranasally infected with 1,000 pfu of PR8 in the
presence (Nasal in red line, n = 8) or absence (Non-treated in black line, n = 8;
Oral in blue line, n = 7) of 1 mg/ml LEM. The mouse survival was monitored for
14 days with (Oral in blue line) or without (Non-treated in black line; Nasal in
red line) the oral administration of 1 mg/ml LEM. Statistical significance was
determined by Gehan–Breslow–Wilcoxon test.
anesthetized mice were inoculated intranasally with 1,000 pfu
of influenza virus in 50 µl PBS containing 1 mg/ml LEM.
For oral administration, 1 mg/ml LEM was provided through
the drinking water after virus infection. The average intake
Frontiers in Microbiology | www.frontiersin.org 3 May 2018 | Volume 9 | Article 1164
fmicb-09-01164 May 29, 2018 Time: 16:43 # 4
Kuroki et al. Anti-influenza Activity of LEM Extracts
amount of LEM was 11.9 ± 2.1 mg/day, and there were no
signs of toxicity in uninfected mice after intranasal or oral
administration of LEM. About 90% of infected mice without
LEM administration died until 13 days post infection, whereas
about 50% of mice intranasally administered with LEM were
recovered from influenza virus infection (Figure 1D; P < 0.05).
There were no significant differences in the survival rate
between control and oral administration groups (P = 0.186).
However, the median survival time of infected mice was
prolonged from 9 to 13 days post infection by the oral
administration of LEM, suggesting that LEM protects mice
from influenza virus infection in part even through the oral
administration.
LEM Directly Inhibits Influenza Virus
Infection at the Early Phases of Infection
To address the mechanism how LEM inhibits influenza virus
growth, we first examined the effect of LEM on viral genome
replication and viral transcription in infected cells. At 7 h post
infection, total RNAs were subjected to reverse transcription
followed by real-time PCR to detect the virus genome RNA and
viral mRNA (Figure 2A). The amounts of virus genome RNA and
viral mRNA in infected cells treated with 300µg/ml LEM reduced
to less than 10% of control cells.
To further examine the effect of LEM on the viral RNA
polymerase activity, we next carried out a viral model replicon
assay in which active viral replicon is reconstituted with
exogenously expressing viral polymerases, NP, and model virus
genome containing firefly luciferase gene (Figure 2B). In this
system, viral factors are expressed from plasmids, therefore
we can focus on the effect of LEM on the viral polymerase
activity without the entry processes of viral particles to host cells.
Figure 2B showed no significant difference between control and
LEM-treated cells in the reporter gene expression. These suggest
that LEM inhibits an entry step(s) such as virus attachment and
uncoating prior to the viral genome replication and transcription.
Effect of LEM on Acute Pulmonary
Influenza Virus Infection
Figure 1D showed that the median survival time of infected
mice is prolonged by the oral administration of LEM. To focus
on the pathogenic insights, mice were infected with 1,000 pfu
of influenza virus with or without the oral administration of
LEM and then dissected at 7 days post infection. In orally
LEM-treated mice, the macroscopic lesions with inflammation,
hemorrhage, and congestion in the lungs were much smaller
than those in mice without LEM administration (Figure 3A).
We next examined histological changes of the lung slices
stained with hematoxylin-eosin (Figures 3B,C). In the absence
of LEM treatment, severe pneumonia with reduced air space of
alveoli, leukocyte infiltration, and desquamation of the bronchial
epithelium were observed (Figure 3B; enlarged figures 3, 4). In
contrast, in the orally LEM-treated mice, there were infiltration
with moderate numbers of leukocytes at the peribronchiolar
areas (Figure 3C; enlarged figure 3), and the extent of alveolitis
was dramatically reduced (Figure 3C; enlarged figures 3, 4).
FIGURE 2 | Lentinula edodes mycelia inhibits the early phases of influenza
virus infection in vitro. (A) Madin-Darby canine kidney (MDCK) cells were
infected with WSN at MOI = 3 in the absence or presence of 300 µg/ml of
LEM. At 7 h post infection, total RNAs were purified and quantitatively
analyzed by reverse transcription followed by real-time PCR with primers
specific for segment 5 viral genome RNA and NP mRNA. The results are
averages from three independent experiments with standard deviations, and
the statistical significance was determined by Student’s t-test. (B) 293T cells
were transfected with plasmids encoding PA, PB1, PB2, and NP genes and a
plasmid for the expression of artificial influenza virus genome encoding
luciferase gene as a reporter in the presence or absence of 300 µg/ml of LEM.
The results are averages from three independent experiments with standard
deviations, and the statistical significance was determined by Student’s t-test.
To quantify the level of leukocyte infiltration, we further
examined the number of leukocytes into the bronchoalveolar
lavage fluid (BALF) by FACS analysis using anti-CD45.2
antibody as a leukocyte marker. As expected, the number
of infiltrating leukocytes in the lungs of orally LEM-treated
mice decreased to about 50% of that without LEM treatment
(Figure 3D).
To address the effect of LEM oral administration on the
innate immune response, the expression levels of TNF-α and
IFN-β in infected lungs were examined. At 3 and 7 days post
infection, the whole lungs were dissected from infected mice
orally administered with 1 mg/ml LEM. Total RNAs extracted
from lungs were subjected to quantitative RT-PCR with primers
specific for TNF-α and IFN-β mRNA, respectively. The oral
administration of LEM led to a slight increase in the expression
of TNF-α mRNA (Figure 4A). IFN-β was induced at 7 days post
infection in non-treated mice, whereas IFN-β was activated at
3 days post infection in the orally LEM-treated mice (Figure 4B).
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FIGURE 3 | Effect of LEM on acute pulmonary influenza virus infection. Mice were intranasally infected with 1,000 pfu of PR8, and then orally administered with
1 mg/ml LEM. At 7 days post infection, the lungs of infected mice were dissected for pathological analysis. (A) shows the gross changes of the lungs. (B) (PBS) and
(C) (LEM administration) show the hematoxylin and eosin-stained sections with enlarged figures. Asterisks indicate bronchioles. Lung section was obtained from two
mice for every group and representative images are shown. Scale bar; 400 and 100 µm (in enlarged panels). In (D) bronchoalveolar lavage fluids (BALF) were
obtained from the dissected lungs (n = 3 for mock-infected group; n = 3 for non-treated infected group; n = 3 for LEM-administrated infected group), and the
number of leukocytes was counted by flow cytometry with anti-CD45.2 antibody, which is a leukocyte marker. The results are averages from three independent
experiments with standard deviations, and the statistical significance was determined by Student’s t-test.
The amount of secreted IFN-β in bronchoalveolar lavage fluid
(BALF) was also measured by ELISA at 3 days post infection. The
amount of IFN-β from the orally LEM-treated mice was about
5 times higher than that from non-treated mice (Figure 4C).
This suggests that the oral administration of LEM induces the
antiviral response more rapidly than non-treated mice via IFN-β
production. Given the lower pathogenicity in orally LEM-treated
mice, we further examined the viral titer in infected lungs at
7 days post infection. We found that the viral titer in infected
lungs orally administered with LEM decreased to less than 50% of
control (Figure 4D). These suggest that the oral administration of
LEM has an immunopotentiation activity of type I IFN response
to inhibit the viral growth, thereby decreases the severity of
pneumonia.
DISCUSSION
In this study, we demonstrated that LEM inhibits influenza virus
infection through the direct action at the early phases of infection,
possibly at entry processes of viral particles. This direct action
of LEM may contribute to improved survival rate of infected
mice nasally administered with LEM. We also found that the oral
administration of LEM stimulates type I IFN response upon virus
infection and prolongs the median survival time of infected mice.
Lentinula edodes mycelia is composed of several kinds
of bioactive compounds, such as polyphenolic compounds,
lentinan (β-1, 3-glucan), and L2 which is a heteropolysaccharide
consisting of glucose, galactose, and arabinose (Zhou et al.,
2009; Xu et al., 2012). It is shown that, among polyphenolic
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FIGURE 4 | The oral administration of LEM enhances type I IFN response. Mice were intranasally infected with 1,000 pfu of PR8, and then orally administered with
1 mg/ml LEM. At 3 and 7 days post infection, total RNAs were prepared from the dissected lungs (n = 2 for mock-infected group; n = 4 for infected group) and the
level of TNF-α (A) and IFN-β mRNA (B) was examined by quantitative RT-PCR. The results are averages from three independent experiments with standard
deviations, and the statistical significance was determined by Student’s t-test. The level of IFN-β in BALF (n = 2 for mock-infected group; n = 5 for infected group)
was examined by ELISA (C). The pulmonary viral titers in infected mice from non-treated group (n = 5) and LEM-administrated group (n = 5) were examined by
focus-forming assays at 7 days post infection (D). The statistical significance was determined by Student’s t-test.
compounds, low molecular weight lignin hydrolysates in LEM
have various pharmacologic activities, such as hepatoprotective,
anti-tumor, and immunomodulatory effects (Sorimachi et al.,
1990; Yamamoto et al., 1997; Yoshioka et al., 2012). Our
results showed that LEM directly inhibits early phases of
influenza virus infection (Figure 2). It is reported that
polyphenols in green tea have anti-influenza activity by blocking
viral adsorption and entry into the host cell (Nakayama
et al., 1993). It is also reported that the fruit body of
Lentinus edodes contains lectins, which are proteins that
bind to specific carbohydrates and glycoproteins (Tsivileva
et al., 2001). Such lectin may inhibit the virus infection
by interacting with glycoconjugated HA and/or sialic acid,
which is an influenza virus receptor expressing cellular plasma
membrane.
Previous studies reported that lentinan, L2, and low molecular
weight lignin hydrolysates possess immunomodulatory activities
(Zhou et al., 2009; Kawano et al., 2010; Xu et al., 2012).
The phenolic hydroxyl group in lignin hydrolysates acts as
a radical scavenger to reduce the level of nitric oxide (NO)
produced from macrophages (Kawano et al., 2010). Lentinan
enhances Th1 immune responses by stimulating maturation
of dendritic cells to inhibit the function of regulatory T cells
(Zhou et al., 2009). L2 increases the level of NO, TNF-α,
and IL-6 produced from macrophages (Xu et al., 2012). In
this study, we found that the oral administration of LEM
stimulates type I IFN response but not proinflammatory response
against influenza virus infection in vivo (Figure 4). Further,
the lung inflammation was mainly observed at peribronchiolar
regions but not alveolar regions of infected lungs by the oral
administration of LEM. In the mouse model, influenza virus
is intranasally inoculated into mice, and directly infects to
bronchiolar epithelium. After the viral growth at peribronchiolar
regions, the progeny viruses spread to distal alveolar regions.
Thus, it is likely that the rapid activation of type I IFN
pathway represses the virus spread to distal alveolar regions
from peribronchiolar regions by inhibiting the viral growth at
bronchiolar epithelium. It is also possible that the activation
of type I IFN pathway inhibits the recruitment of neutrophils
as well as the excess production of proinflammatory cytokines
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from macrophages that may induce tissue inflammation and
lung damages (Seo et al., 2011; Xing et al., 2016). Taken
together, our findings suggest that LEM has anti-influenza virus
activity through the direct action on virus infection and the
immunopotentiation activity of type I IFN response.
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